Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.56 |
| ▸ | NOD1 | Q9Y239 | 7/20 | 0.53 |
| ▸ | TLR2 | O60603 | 5/20 | 0.49 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.48 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.46 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7803299 | 1.00 | SLC6A5 (0.56) | SLC6A5NOD1TLR2SIRT1SIRT6 | |
| SCHEMBL30915502 | 1.00 | SLC6A5 (0.56) | SLC6A5NOD1TLR2SIRT1SIRT6 | |
| SCHEMBL7804955 | 1.00 | SLC6A5 (0.56) | SLC6A5NOD1TLR2SIRT1SIRT6 | |
| SCHEMBL7804980 | 1.00 | SLC6A5 (0.56) | SLC6A5NOD1TLR2SIRT1SIRT6 | |
| SCHEMBL8760314 | 0.96 | NOD1 (0.54) | SLC6A5NOD1TLR2SIRT1EPHX1 | |
| SCHEMBL5855445 | 0.94 | NOD1 (0.52) | SLC6A5NOD1TLR2SIRT1FOLH1 | |
| SCHEMBL457463 | 0.94 | SLC6A5 (0.52) | SLC6A5NOD1TLR2SIRT1SIRT6 | |
| SCHEMBL5855451 | 0.94 | NOD1 (0.52) | SLC6A5NOD1TLR2SIRT1FOLH1 | |
| SCHEMBL7534565 | 0.94 | SLC6A5 (0.52) | SLC6A5NOD1TLR2SIRT1SIRT6 | |
| SCHEMBL2356099 | 0.94 | SLC6A5 (0.52) | SLC6A5NOD1TLR2SIRT1SIRT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010055620-A1 | New lysine derivatives containing an Ne-alkoxy or Ne-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions | L'OREAL | 2001-12-27 | — | — | US | claimed |
| EP-0652209-B1 | Derivatives of N-epsilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions | OREAL (FR) | 1998-04-08 | — | — | EP | claimed |
| EP-0652209-A1 | Derivatives of N-episilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions | L'OREAL (FR) | 1995-05-10 | — | — | EP | claimed |
| US-20010055620-A1 | New lysine derivatives containing an Ne-alkoxy or Ne-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions | L'OREAL | 2001-12-27 | — | — | US | disclosed |
| US-6207173-B1 | Lysine derivatives containing an Nε-alkoxy or Nε-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions | L'OREAL (FR) | 2001-03-27 | — | — | US | disclosed |
| EP-0652209-B1 | Derivatives of N-epsilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions | OREAL (FR) | 1998-04-08 | — | — | EP | disclosed |
| EP-0652209-A1 | Derivatives of N-episilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions | L'OREAL (FR) | 1995-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010055620-A1 | New lysine derivatives containing an Ne-alkoxy or Ne-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions | DOT1L, KDM7A, JMJD6 | SLC6A5 4298/4885NOD1 2327/4885TLR2 1775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.